Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy

Total article views   HTML views PDF downloads Totals
5,048 Dovepress* 4,645+ 850 5,495
PubMed Central* 403 161 564
Totals 5,048 1,011 6,059
*Since 29 October 2020

View citations on PubMed Central and Google Scholar